
Outsourced services can provide significant financial and risk-avoidance benefits

Good growth is occurring in the vaccine business, despite the hurdles of public perceptions and public-health funding shortfalls


The rise in product volume is more than matched by the rise of regulatory constraints

A 'performance curve' chart for containers could simplify the design process


Design analysis can dictate blister composition


Looking at the essential value of well-managed supply chains

IMS Health/Ego Zender survey of CIOs finds short tenures and evolving skill sets

HDMA seeks to encourage more outreach to business partners and government

Despite a flurry of specialty pharmaceuticals in innovative formats, traditional powder-based dosages will always be a mainstay


'Average Manufacturer Price' is now a mostly settled matter

Agency plans new guidance in traceability, REMS and biosimilarity, among others

Sonoco ThermoSafe's device provides 120 hours of on-spec performance

rfXcel and Covectra announce new versions of their DSCSA-compliant software

Personalized Medicine Coalition notes uptick in diagnostic-influenced drug approvals

Pharmacies sue PBMs for restraint of trade, while payers question their activities

Deal value soared above $300 billion in 2015, but will the dealmaking sustain Big Pharma companies?

Industry is doing better at filing studies, but the agency is falling behind reviews, says GAO

A 'moon shot' to cure cancer is part of Obama's last Address

Controlled environment protects cold chain shipments in transit

Construction index shows a steady level of North American activity

ZIMonitor tracking service provides remote monitoring

'Innovation' is the recurring theme

HDMA's 2015-16 Factbook updates member financial, operational performance

Combination expands breadth of commercialization and compliance services

List includes 21 new orphan drugs, and of the 45, 15 are cold chain products